Description
NovoNorm (Repaglinide) Tablets 1 mg
Ingredients:
- Each tablet contains 1 mg of Repaglinide.
Dosage:
- The recommended dose is 1 mg taken orally before each main meal.
Indications:
- NovoNorm (Repaglinide) tablets are indicated for the treatment of type 2 diabetes mellitus.
Contraindications:
- Do not use NovoNorm (Repaglinide) tablets in patients with type 1 diabetes or diabetic ketoacidosis.
Directions:
- Take NovoNorm (Repaglinide) tablets orally before each main meal. Follow the dosage instructions provided by your healthcare provider.
Scientific Evidence:
Studies have shown that Repaglinide effectively lowers blood glucose levels by stimulating insulin release from the pancreas. This mechanism of action helps control postprandial hyperglycemia in patients with type 2 diabetes.
Additional Information:
- It is important to monitor blood glucose levels regularly while taking NovoNorm tablets to adjust the dosage as needed.
- This medication should be used as part of a comprehensive treatment plan that includes diet and exercise.
Research has demonstrated the efficacy of Repaglinide in improving glycemic control and reducing HbA1c levels in patients with type 2 diabetes. Clinical trials have also shown that NovoNorm tablets have a rapid onset of action and a short duration, making it a suitable option for managing postprandial glucose spikes.
